hVIVO PLC (AIM:HVO) chief executive Mo Khan speaks to Thomas Warner from Proactive after announcing that the specialist contract research organisation has partnered with a North American biopharmaceutical company to create the industry's first commercial hMPV human challenge model.
Khan says he's "very happy with the signing of this contract" before going to explain the significance of the news for hVIVO investors as well as for patients.